Abstract
Ménière’s disease (MD), which by definition is idiopathic, has been ascribed to various causes, including both inhalant and food allergies. Patients with MD report higher rates of allergy history and positive skin or in vitro tests compared to a control group of patients with other otologic diseases and to the general public. Recent immunologic studies have shown higher rates of circulating immune complexes, CD4, and other immunologic components in patients with MD compared to normal controls. Published treatment results have shown benefit from immunotherapy and/or dietary restriction for symptoms of MD in patients with both allergy and MD.
Similar content being viewed by others
References and Recommended Reading
Ménière P: Pathologieauriculaire: mémoire sur des lésions de l’oreille interne donnant lieu a des symptomes de congestion cerebrale apoplectiforme. Gaz Med Paris 1861, 16:597–601.
American Academy of Otolaryngology—Head and Neck Foundation: Committee on Hearing and Equilibrium guidelines for the diagnosis and evaluation of therapy in Ménière’s disease. Otolaryngol Head Neck Surg 1995, 113:181–185.
Wladislavosky-Waserman P, Facer GW, Mokri B, Kurland LT: Meniere’s disease: a 30-year epidemiologic and clinical study in Rochester, MN, 1951–1980. Laryngoscope 1984, 94:1098–1102.
Duke W: Meniere’s syndrome caused by allergy. JAMA 1923, 81:2179–2182.
Powers WH: Allergic factors in Ménière’s disease. Trans Am Acad Opthalmol Otolaryngol 1973, 77:22.
House JW, Doherty JK, Fisher LM, et al.: Meniere’s disease: Prevalence of contralateral ear involvement. Otol Neurotol 2006, 27:355–361.
Derebery MJ, Berliner KI: Characteristics, onset and progression in Meniere’s disease. In Proceedings of the 5th International Symposium on Meniere’s Disease and Inner Ear Homeostasis Disorders. Edited by Lim DJ. Los Angeles: House Ear Institute; 2005:128–130.
Harris JP, Keithley EM, Ballenger S: Autoimmune inner ear disease. In Otorhinolaryngology Head and Neck Surgery, edn 16. Edited by Snow JB, Ballenger JJ. Hamilton, Ontario: BC Decker; 2003:396–407.
Harris JP: Immunology of the inner ear: response of the inner ear to antigen challenge. Otolaryngol Head Neck Surg 1983, 91:18–23.
Stearns GS, Keithley EM, Harris JP: Development of high endothelial venule-like characteristics in the spiral modiolar vein induced by viral labyrinthitis. Laryngoscope 1993, 103:890–898.
Hashimoto S, Billings P, Harris JP, et al.: Innate immunity contributes to cochlear adaptive immune responses. Audiol Neurootol 2005, 10:35–43.
Altermatt HJ, Gebbers JO, Müller C, et al.: Human endolymphatic sac: evidence for a role in inner ear immune defence. ORL J Otorhinolaryngol Relat Spec 1990, 52:143–148.
Uno K, Miyamura K, Kanzaki Y, et al.: Type I allergy in the inner ear of the guinea pig. Ann Otol Rhinol Laryngol 1992, 101(Suppl 157):78–81.
Harris JP: Immunology of the inner ear: evidence of local antibody production. Ann Otol Rhinol Laryngol 1984, 93:157–162.
Tomiyama S, Harris JP: The role of the endolymphatic sac in inner ear immunity. Acta Otolaryngol 1987, 103:182–188.
Wackym PA, Friberg U, Linthicum FH Jr, et al.: Human endolymphatic sac: morphologic evidence of immunologic function. Ann Otol Rhinol Laryngol 1987, 96:276–281.
Gadre AK, Fayad JN, O’Leary MJ, et al.: Arterial supply of the human endolymphatic duct and sac. Otolaryngol Head Neck Surg 1993, 108:141–148.
Harris JP, Ryan AF: Fundamental immune mechanisms of the brain and inner ear. Otolaryngol Head Neck Surg 1995, 112:639–653.
Derebery MJ: Allergic management of Ménière’s disease: an outcome study. Otolaryngol Head Neck Surg 2000, 122:174–182.
Yan Z, Wang JB, Gong SS, Huang X: Cell proliferation in the endolymphatic sac in situ after the rat Waldeyer ring equivalent immunostimulation. Laryngoscope 2003, 113:1609–1614.
Brookes GB: Circulating immune complexes in Ménière’s disease. Arch Otolaryngol Head Neck Surg 1986, 112:536–540.
Derebery MJ, Rao VS, Siglock TJ, et al.: Ménière’s disease: an immune complex-mediated illness? Laryngoscope 1991, 101:225–229.
Leone CA, Feghali JG, Linthicum FH Jr: Endolymphatic sac: possible role in autoimmune sensorineural hearing loss. Ann Otol Rhinol Laryngol 1984, 93:208–209.
Derebery MJ, Berliner KI: Prevalence of allergy in Ménière’s disease. Otolaryngol Head Neck Surg 2000, 123:69–75.
Atkinson M: Migraine and Meniere’s disease. Arch Otolaryngol 1962, 75:48–51.
Hinchcliffe R: Headache and Meniere’s disease. Acta Otolaryngol 1967, 63:384–390.
Dolowitz DA: Meniere’s—an inner ear seizure. Laryngoscope 1979, 89:67–77.
Radtke A, Lempert T, Gresty MA, et al.: Migraine and Meniere’s disease: is there a link? Neurology 2002, 5:1700–1704.
Sen P, Georgalas C, Papesch M: Co-morbidity of migraine and Meniere’s disease: is allergy the link? J Laryngol Otol 2005, 119:455–460.
Paparella MM, Djalilian HR: Etiology, pathophysiology of symptoms, and pathogenesis of Meniere’s disease. Otolaryngol Clin N Am 2002, 35:529–545.
Savastano M, Giacomelli L, Marioni G: Non-specific immunological determinations in Meniere’s disease: any role in clinical practice? Eur Arch Otorhinolaryngol 2007, 264:15–19.
Keles E, Godekmerdan A, Kalidag T, et al.: Meniere’s disease and allergy: allergens and cytokines. J Laryngol Otol 2004, 118:688–693.
Jeck-Thole S, Wagner W: Betahistine: a retrospective synopsis of safety data. Drug Safety 2006, 29:1049–1059.
Hill SJ, Ganellin CR, Timmerman H, et al.: International Union of Pharmacology, XIII. Classification of histamine receptors. Pharmacol Rev 1997, 49:253–277.
Liu C, Ma XJ, Jiang X, et al.: Cloning and pharmacological characterization of a fourth histamine receptor (H4) expressed in bone marrow. Mol Pharmacol 2001, 5:420–426.
Arrang JM, Garbarg M, Quach TT, et al.: Actions of beta-histine at histamine receptors in the brain. Eur J Pharmacol 1985, 111:73–844.
Curwain BP, Holton P, Spencer J: The effect of betahistine on gastric acid secretion and mucosal blood flow in conscious dogs. Br J Pharmacol 1972, 46:351–354.
West RE, Zweig A, Shih NY et al.: Identification of two H3-histamine receptors subtypes. Mol Pharmacol 1990, 38:610–613.
Laurikainen EL, Miller JM, Nutall AL: The vascular mechanism of action betahistine in the inner ear of the guinea pig. Eur Arch Otorhinolaryngol 1998, 255:119–123.
Dziadziola JK, Laurikian EL, Rachel JD: Betahistine increases vestibular blood flow. Otolaryngol Head Neck Surg 1999, 120:400–405.
Kohno S, Nakao S, Ogawa K, et al.: Possible participation of histamine H3-receptors in the regulation of anaphylactic histamine release from isolated rat peritoneal mast cells. Jpn J Pharmacol 1994, 66:173–180.
Derebery MJ, Berliner KI: Allergic management in Ménière’s disease: a prospective study. Presented at the American Academy of Otolaryngic Allergy annual meeting. Orlando, FL; September 19, 2003.
Yang X: Does allergen immunotherapy alter the natural course of allergic disorders? Drugs 2001, 61:365–374.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Derebery, M.J., Berliner, K.I. Allergy and Ménière’s disease. Curr Allergy Asthma Rep 7, 451–456 (2007). https://doi.org/10.1007/s11882-007-0069-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11882-007-0069-0